Twi Pharmaceuticals Inc., of Taipei, Taiwan, appointed Ming Chen interim president and CEO. Chen is the founder of Twi and has been the chief architect of the company’s strategy. He will focus on operating strategies, making precise product selections, motivating top management and all employees, and integrating the business groups’ resources to strengthen core competencies.

No Comments